Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer

NCT00251095 is registered in ClinicalTrials.gov with Achieve Life Sciences as lead sponsor.

NCT NCT00251095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00251095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer
Lead sponsor
Achieve Life Sciences
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2005
Completion date
September 30, 2007
Enrollment
821 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm